Phreesia has raised more than $167m in proceeds after pricing shares above its range at $18, providing exits to BlueCross BlueShield, Ascension Health and Echo Health Ventures.

US-based patient engagement technology provider Phreesia priced its shares at $18 on Wednesday and raised more than $167m in proceeds when it began trading on the New York Stock Exchange yesterday. The offering provided exits to corporate venturing units BlueCross BlueShield Venture Partners, Ascension Ventures and Echo Health Ventures. The company sold approximately 9.3 million…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.